TrialScope has been selected by H. Lundbeck A/S as its partner for maintaining disclosure compliance. Lundbeck is a global pharmaceutical company focusing on brain health. Lundbeck will have access to TrialScope’s full range of disclosure services, including protocol registration, study results disclosure, redaction and plain-language summaries (PLS), managed with the TrialScope Disclose™ platform to provide consistency and efficiency across disclosure activities.
“At TrialScope, we are proud to be market leaders delivering the most trusted and comprehensive clinical trial disclosure solution,” said TrialScope CEO Jeff Kozloff. “In addition to our transparency cloud technology, our expert-level disclosure services lessen the compliance burden for sponsors. We are extremely excited to add Lundbeck to the TrialScope disclosure community, and we look forward to an ongoing, successful partnership.”
Subscribe to our e-Newsletters
Stay up to date with the latest news, articles, and events. Plus, get special offers
from Pharmaceutical Outsourcing – all delivered right to your inbox! Sign up now!
“We chose TrialScope because of its deep expertise in clinical trial disclosure,” said Kerstin Dahlström, Lundbeck Director Transparency & Outsourcing. “The regulatory requirements for disclosure compliance are numerous and complex. We wanted a partner with a proven track record, a partner that we could rely on, one that we could work with as a de facto extension of our internal disclosure team.”